- Akademik Gastroenteroloji Dergisi
- Cilt: 22 Sayı: 3
- Hepatotoxicity case due to interferon beta-1a use
Hepatotoxicity case due to interferon beta-1a use
Authors : Ramazan Yolaçan, Bekir Kaya, Ümit Karabulut, Ali Üzel, Feyzullah Uçmak, Muhsin Kaya
Pages : 164-167
Doi:10.17941/agd.1333370
View : 18 | Download : 47
Publication Date : 2023-12-22
Article Type : Other
Abstract :Interferon β-1a is an immunomodulatory drug widely used in the treatment of multiple sclerosis. Liver dysfunction is a common side effect of this drug and usually develops within the first 6 months of starting interferon therapy. Here, we present our case who developed hepatotoxicity secondary to interferon β-1a treatment.Keywords : Multipl skleroz, karaciğer fonksiyon bozukluğu, interferon β